News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
267,419 Results
Type
Article (14229)
Company Profile (281)
Press Release (252909)
Multimedia
Podcasts (48)
Webinars (7)
Section
Business (79518)
Career Advice (153)
Deals (13225)
Drug Delivery (35)
Drug Development (50455)
Employer Resources (31)
FDA (5721)
Job Trends (5132)
News (144414)
Policy (10031)
Tag
2024 BioCapital Digital (6)
2024 BioForest Digital (1)
2024 BioMidwest Digital (4)
2024 Bio NC Digital (4)
2024 Biotech Bay Standard (10)
2024 Biotech Beach Digital (5)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (7)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (4)
2024 Pharm Country Standard (3)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (3)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Elite (1)
2026 Pharm Country Standard (1)
Academia (914)
Accelerated approval (2)
Adcomms (12)
Allergies (51)
Alliances (21662)
ALS (63)
Alzheimer's disease (844)
Antibody-drug conjugate (ADC) (89)
Approvals (5743)
Artificial intelligence (120)
Autoimmune disease (17)
Automation (5)
Bankruptcy (105)
Best Places to Work (4559)
BIOSECURE Act (6)
Biosimilars (42)
Biotechnology (232)
Bladder cancer (49)
Brain cancer (20)
Breast cancer (148)
Cancer (1381)
Cardiovascular disease (116)
Career advice (133)
Career pathing (2)
CAR-T (112)
Cell therapy (317)
Cervical cancer (8)
Clinical research (41001)
Collaboration (521)
Compensation (255)
Complete response letters (13)
COVID-19 (1034)
CRISPR (39)
C-suite (155)
Cystic fibrosis (76)
Data (1432)
Denatured (11)
Depression (29)
Diabetes (131)
Diagnostics (1294)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (82)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (88)
Earnings (29746)
Editorial (18)
Employer branding (4)
Employer resources (29)
Events (48327)
Executive appointments (446)
FDA (6393)
Featured Employer (30)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (486)
Gene editing (93)
Generative AI (10)
Gene therapy (240)
GLP-1 (364)
Government (1078)
Grass and pollen (2)
Guidances (19)
Healthcare (6593)
Huntington's disease (22)
IgA nephropathy (22)
Immunology and inflammation (88)
Indications (19)
Infectious disease (1099)
Inflammatory bowel disease (111)
Inflation Reduction Act (8)
Influenza (19)
Intellectual property (62)
Interviews (17)
IPO (7267)
IRA (11)
Job creations (860)
Job search strategy (127)
Kidney cancer (6)
Labor market (5)
Layoffs (206)
Leadership (3)
Legal (1386)
Liver cancer (31)
Lung cancer (194)
Lymphoma (92)
Machine learning (2)
Management (7)
Manufacturing (130)
MASH (50)
Medical device (2595)
Medtech (2596)
Mergers & acquisitions (6278)
Metabolic disorders (378)
Multiple sclerosis (51)
NASH (13)
Neurodegenerative disease (63)
Neuropsychiatric disorders (23)
Neuroscience (1235)
NextGen: Class of 2025 (2017)
Non-profit (852)
Northern California (1634)
Now hiring (22)
Obesity (192)
Opinion (102)
Ovarian cancer (61)
Pain (41)
Pancreatic cancer (53)
Parkinson's disease (119)
Partnered (8)
Patents (124)
Patient recruitment (72)
Peanut (35)
People (25600)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14480)
Phase II (19073)
Phase III (12060)
Pipeline (775)
Policy (44)
Postmarket research (852)
Preclinical (6081)
Press Release (30)
Prostate cancer (58)
Psychedelics (35)
Radiopharmaceuticals (212)
Rare diseases (286)
Real estate (1418)
Recruiting (12)
Regulatory (8607)
Reports (15)
Research institute (938)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (4)
RSV (10)
Schizophrenia (57)
Series A (95)
Series B (60)
Service/supplier (1)
Sickle cell disease (40)
Southern California (1435)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (11)
Startups (1972)
State (1)
Stomach cancer (4)
Supply chain (21)
Tariffs (5)
The Weekly (36)
United States (12761)
Vaccines (208)
Venture capitalists (30)
Weight loss (109)
Women's health (15)
Worklife (2)
Date
Today (63)
Last 7 days (257)
Last 30 days (1396)
Last 365 days (19539)
2025 (5596)
2024 (20553)
2023 (22414)
2022 (26822)
2021 (27805)
2020 (23356)
2019 (16223)
2018 (11738)
2017 (13745)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (148)
Alabama (41)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17266)
Australia (2930)
California (3709)
Canada (1105)
China (338)
Colorado (144)
Connecticut (149)
Delaware (94)
Europe (37138)
Florida (445)
Georgia (115)
Idaho (16)
Illinois (221)
India (10)
Indiana (91)
Iowa (1)
Japan (73)
Kansas (61)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (464)
Massachusetts (2937)
Michigan (70)
Minnesota (142)
Mississippi (1)
Missouri (24)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (14)
New Jersey (935)
New Mexico (12)
New York (1007)
North Carolina (538)
North Dakota (4)
Northern California (1634)
Ohio (110)
Oklahoma (9)
Oregon (21)
Pennsylvania (704)
Puerto Rico (5)
Rhode Island (18)
South America (208)
South Carolina (4)
Southern California (1435)
Tennessee (25)
Texas (427)
Utah (50)
Virginia (76)
Washington D.C. (30)
Washington State (339)
Wisconsin (14)
267,419 Results for "coya therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Coya Therapeutics Announces Publication of GLP-1/LD IL-2 Combination Biologic (COYA 303) Demonstrating Synergistic Enhancement of Regulatory T Cell Function and Protection Against Treg Apoptosis (Cell Death)
April 21, 2025
·
8 min read
Press Releases
Coya Therapeutics Selected for Platform Presentation at the ADPD 2025 Conference in Vienna on April 5, 2025
April 1, 2025
·
5 min read
Press Releases
Coya Therapeutics Provides a Corporate Update and Reports Fiscal 2024 Financial Results
March 18, 2025
·
14 min read
Press Releases
Coya Therapeutics Announces Pipeline Expansion - COYA 303: COYA 301 in Combination with GLP-1 Receptor Agonist for the Treatment of Inflammatory Diseases
January 21, 2025
·
7 min read
Press Releases
Coya Therapeutics Reports Progress from an Academic Supported First-in-Class Treg-derived Exosome Program
March 27, 2025
·
7 min read
Press Releases
Coya Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
February 4, 2025
·
6 min read
Lone Star Bio
Coya Therapeutics Issues Letter to Stockholders Highlighting Expansion of COYA 302 into Alzheimer’s Disease and Coya’s Pathway to a “Pipeline in a Product”
Coya Therapeutics Issues Letter to Stockholders Highlighting Expansion of COYA 302 into Alzheimer’s Disease and Coya’s Pathway to a “Pipeline in a Product”.
February 21, 2024
·
19 min read
Lone Star Bio
Coya Therapeutics Announces Acceptance of Peer-Reviewed Manuscript in the Medical Journal: Frontiers in Neurology
Coya Therapeutics, Inc. announces the acceptance of a peer-reviewed manuscript.
June 3, 2024
·
10 min read
Press Releases
Coya Therapeutics to Participate in KOL Call Hosted by BTIG to Discuss the Potential Treatment of Alzheimer’s Disease Using GLP-1 Agonists and Combinations
February 26, 2025
·
6 min read
Business
Coya Therapeutics Expands Sponsored Research Collaboration with Houston Methodist Research Institute
Coya Therapeutics, Inc. announces the expansion of its research collaboration with the Houston Methodist Research Institute (“HMRI”) through a sponsored research agreement (SRA) covering multiple initiatives.
June 20, 2024
·
10 min read
1 of 26,742
Next
